Old Web
English
Sign In
Acemap
>
Paper
>
Health Canada’s perspective on the clinical development of biosimilars and related scientific and regulatory challenges
Health Canada’s perspective on the clinical development of biosimilars and related scientific and regulatory challenges
2015
Ally Pen
Agnes V. Klein
Jian Wang
Keywords:
Biosimilar
Pharmacology
Medicine
Engineering ethics
Political science
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI
[]